Nephron Research upgraded Bruker (BRKR) to Hold from Sell.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BRKR:
- Morning Movers: Kenvue surges, Kimberly-Clark sinks after tie up
- Bruker cuts FY25 EPS view to $1.85-$1.90 from $1.95-$2.05, consensus $1.94
- Bruker reports Q3 EPS 45c, consensus 33c
- BRKR Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Bruker Inc: Promising Product Launches Amid Market Uncertainties Lead to Hold Rating